Seth Goldfarb
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Treatment of Major Depression
Papers in
-
- Lung Cancer Treatments and Mutations 1
-
- Botulinum Toxin and Related Neurological Disorders 1
- Co-authors
- C. Anthony Altar (1 shared paper)Kelly Parsons (1 shared paper)Gabriela Lavezzari (1 shared paper)Joseph Carhart (1 shared paper)Josiah D. Allen (1 shared paper)Joel G Winner (1 shared paper)Bryan Dechairo (1 shared paper)Vivian Herrera (2 shared papers)
- Journals
- Current Medical Research and Opinion (2 papers)Neurology (1 paper)Journal of Clinical Oncology (1 paper)The American journal of geriatric pharmacotherapy (1 paper)International Journal of COPD (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
Seth Goldfarb
5 papers receiving 147 citations
Peers
Comparison fields: 5 of 50
- Pharmacology 59
- Family Practice 11
- Biological Psychiatry 9
- Issues, ethics and legal aspects 4
- Geriatrics and Gerontology 9
Countries citing papers authored by Seth Goldfarb
This map shows the geographic impact of Seth Goldfarb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth Goldfarb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth Goldfarb more than expected).
Fields of papers citing papers by Seth Goldfarb
This network shows the impact of papers produced by Seth Goldfarb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth Goldfarb. The network helps show where Seth Goldfarb may publish in the future.
Co-authors
The 25 scholars most cited alongside Seth Goldfarb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 81 | |
| 2 | 2018 | 20 | |
| 3 | 2013 | 20 | |
| 4 | 2019 | 18 | |
| 5 | 2011 | 14 | |
| 6 | 2023 | 0 |
About Seth Goldfarb
Seth Goldfarb is a scholar working on Pulmonary and Respiratory Medicine, Neurology, Cardiology and Cardiovascular Medicine, Family Practice and Issues, ethics and legal aspects, having authored 6 papers that have together received 153 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (1 paper), Cancer Genomics and Diagnostics (1 paper), IL-33, ST2, and ILC Pathways (1 paper), Heart Failure Treatment and Management (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper), Bipolar Disorder and Treatment (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Botulinum Toxin and Related Neurological Disorders (1 paper). The work is most often cited by research in Pharmacology (59 citations), Family Practice (11 citations), Biological Psychiatry (9 citations), Issues, ethics and legal aspects (4 citations) and Geriatrics and Gerontology (9 citations). Seth Goldfarb has collaborated with scholars based in United States and France. Frequent co-authors include C. Anthony Altar, Kelly Parsons, Gabriela Lavezzari, Joseph Carhart, Josiah D. Allen, Joel G Winner, Bryan Dechairo, Vivian Herrera, Shuchita Kaila and Michael H. Gelb. Their work appears in journals such as Current Medical Research and Opinion, Neurology, Journal of Clinical Oncology, The American journal of geriatric pharmacotherapy and International Journal of COPD.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.